• Latest Posts

First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors

Argenx Raises Whopping €502M in Global Offering

EU Project Receives €15M to Bring mRNA Therapy to a Wider Audience

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines

UK Scientists Speed up Brain Cancer Diagnosis with AI

ADVERTISEMENT

EU Regulations Are Holding Back Gene and Cell Therapy Clinical Trials

Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes

European Project Launches to Tailor Autoimmune Disease Treatments

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

AI-Driven Antibiotic Susceptibility Test Launched in Austria

ADVERTISEMENT